Skip to main content

Advertisement

Table 2 Pattern of expression of Id1 and Id3 proteins in the 17 evaluable patients

From: Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Patient number Tissue Staining intensity Percentage of staining H-score
Id1 Id3 Id1 Id3 Id1 Id3
10 LB 1 0 2 0 2 0
2 BB 2 1 3 1 6 1
3 BB 2 2 1 1 2 2
5 BB 1 1 1 1 1 1
6 BB 1 1 2 1 2 1
7 BB 2 1 2 2 4 2
8 BB 1 0 3 0 3 0
1 LNB 3 3 3 2 9 6
11 LNB 0 0 0 0 0 0
4 CB 0 0 0 0 0 0
9 CB 1 0 2 0 2 0
12 C 0 0 0 0 0 0
13 C 1 0 2 0 2 0
14 C 0 0 0 0 0 0
15 C 1 0 2 0 2 0
16 C 1 0 1 0 1 0
17 C 1 1 2 1 2 1
  1. Tissue sample: LB (lung biopsy), BB (bronchial biopsy), LNB (lymph node biopsy), CB (cell block sample), C (cytology sample). Staining intensity (0: no staining, 1: weak, 2: moderate, 3: strong staining). Percentage of staining (0 = 0%, 1 = 0-5%, 2 = 5-50%, 3 > 50%).